IGC Pharma annual debt-to-assets ratio
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
IGC Pharma Debt-to-Assets Ratio Growth & History (IGC)
IGC Pharma's debt-to-assets ratio was 0.01 for fiscal 2025.
View full IGC Pharma company overviewIGC Pharma annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | 0.01 | — | — |
| 2025 · Mar 31 | 2025-03-31 | 0.03 | −0.01 | −21.93% |
| 2024 | 2024-03-31 | 0.04 | 0.01 | +24.73% |
| 2023 | 2023-03-31 | 0.03 | 0.01 | +23.74% |
| 2022 | 2022-03-31 | 0.02 | −0.01 | −24.03% |
| 2021 | 2021-03-31 | 0.03 | 0.01 | +39.22% |
| 2020 | 2020-03-31 | 0.02 | 0.02 | +1384.00% |
| 2019 | 2019-03-31 | 0.00 | 0.00 | — |
| 2018 | 2018-03-31 | 0.00 | −0.04 | — |
| 2017 | 2017-03-31 | 0.04 | −0.00 | −8.89% |
| 2016 | 2016-03-31 | 0.04 | −0.03 | −44.28% |
| 2015 | 2015-03-31 | 0.08 | 0.08 | — |
| 2014 | 2014-03-31 | 0.00 | 0.00 | — |
| 2013 | 2013-03-31 | 0.00 | 0.00 | — |
| 2012 | 2012-03-31 | 0.00 | −0.05 | — |
| 2011 | 2011-03-31 | 0.05 | — | — |
IGC Pharma quarterly debt-to-assets ratio
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | 0.00 | −0.03 | — |
| Q1 2026 · Mar 31 | 2026-03-31 | 0.00 | −0.03 | −96.43% |
| Q4 2025 · Dec 31 | 2025-12-31 | 0.01 | −0.02 | −50.35% |
| Q2 2026 · Sep 30 | 2025-09-30 | 0.02 | −0.01 | −48.00% |
| Q1 2026 · Jun 30 | 2025-06-30 | 0.03 | −0.01 | −19.82% |
| Q4 2025 · Mar 31 | 2025-03-31 | 0.03 | −0.01 | −21.93% |
| Q3 2025 | 2024-12-31 | 0.03 | −0.00 | −10.90% |
| Q2 2025 | 2024-09-30 | 0.03 | 0.00 | +16.91% |
| Q1 2025 | 2024-06-30 | 0.03 | 0.00 | +11.86% |
| Q4 2024 | 2024-03-31 | 0.04 | 0.01 | +24.73% |
| Q3 2024 | 2023-12-31 | 0.03 | 0.01 | +31.53% |
| Q2 2024 | 2023-09-30 | 0.03 | 0.00 | +1.47% |
| Q1 2024 | 2023-06-30 | 0.03 | 0.00 | +19.90% |
| Q4 2023 | 2023-03-31 | 0.03 | 0.01 | +23.74% |
| Q3 2023 | 2022-12-31 | 0.03 | 0.01 | +25.06% |
| Q2 2023 | 2022-09-30 | 0.02 | 0.01 | +26.04% |
| Q1 2023 | 2022-06-30 | 0.02 | 0.00 | +18.61% |
| Q4 2022 | 2022-03-31 | 0.02 | −0.01 | −24.03% |
| Q3 2022 | 2021-12-31 | 0.02 | −0.02 | −54.76% |
| Q2 2022 | 2021-09-30 | 0.02 | −0.02 | −53.25% |
| Q1 2022 | 2021-06-30 | 0.02 | −0.02 | −51.67% |
| Q4 2021 | 2021-03-31 | 0.03 | 0.01 | +39.22% |
| Q3 2021 | 2020-12-31 | 0.05 | 0.04 | +2721.49% |
| Q2 2021 | 2020-09-30 | 0.04 | 0.04 | +2686.15% |
| Q1 2021 | 2020-06-30 | 0.04 | 0.04 | +2705.99% |
| Q4 2020 | 2020-03-31 | 0.02 | 0.02 | +1384.00% |
| Q3 2020 | 2019-12-31 | 0.00 | 0.00 | — |
| Q2 2020 | 2019-09-30 | 0.00 | 0.00 | — |
| Q1 2020 | 2019-06-30 | 0.00 | 0.00 | — |
| Q4 2019 | 2019-03-31 | 0.00 | 0.00 | — |
| Q3 2019 | 2018-12-31 | 0.00 | 0.00 | — |
| Q2 2019 | 2018-09-30 | 0.00 | −0.04 | — |
| Q1 2019 | 2018-06-30 | 0.00 | −0.02 | — |
| Q4 2018 | 2018-03-31 | 0.00 | −0.04 | — |
| Q3 2018 | 2017-12-31 | 0.00 | −0.04 | — |
| Q2 2018 | 2017-09-30 | 0.04 | 0.00 | +1.28% |
| Q1 2018 | 2017-06-30 | 0.02 | −0.01 | −43.35% |
| Q4 2017 | 2017-03-31 | 0.04 | −0.00 | −8.89% |
| Q3 2017 | 2016-12-31 | 0.04 | −0.02 | −38.07% |
| Q2 2017 | 2016-09-30 | 0.03 | −0.01 | −19.00% |
| Q1 2017 | 2016-06-30 | 0.03 | −0.04 | −57.28% |
| Q4 2016 | 2016-03-31 | 0.04 | −0.03 | −44.28% |
| Q3 2016 | 2015-12-31 | 0.06 | 0.05 | +316.63% |
| Q2 2016 | 2015-09-30 | 0.04 | 0.03 | +158.22% |
| Q1 2016 | 2015-06-30 | 0.08 | 0.06 | +350.51% |
| Q4 2015 | 2015-03-31 | 0.08 | 0.08 | — |
| Q3 2015 | 2014-12-31 | 0.02 | 0.02 | — |
| Q2 2015 | 2014-09-30 | 0.02 | 0.02 | — |
| Q1 2015 | 2014-06-30 | 0.02 | 0.02 | — |
| Q4 2014 | 2014-03-31 | 0.00 | 0.00 | — |
| Q3 2014 | 2013-12-31 | 0.00 | −0.00 | — |
| Q2 2014 | 2013-09-30 | 0.00 | −0.01 | — |
| Q1 2014 | 2013-06-30 | 0.00 | −0.01 | — |
| Q4 2013 | 2013-03-31 | 0.00 | 0.00 | — |
| Q3 2013 | 2012-12-31 | 0.00 | −0.02 | −99.02% |
| Q2 2013 | 2012-09-30 | 0.01 | −0.04 | −85.61% |
| Q1 2013 | 2012-06-30 | 0.01 | −0.04 | −84.29% |
| Q4 2012 | 2012-03-31 | 0.00 | −0.05 | — |
| Q3 2012 | 2011-12-31 | 0.02 | — | — |
| Q2 2012 | 2011-09-30 | 0.05 | — | — |
| Q1 2012 | 2011-06-30 | 0.05 | — | — |
| Q4 2011 | 2011-03-31 | 0.05 | — | — |
IGC Pharma debt-to-assets ratio trends
Between the periods ended 2011-03-31 and 2025-12-31, IGC Pharma's debt-to-assets ratio decreased from 0.05 to 0.01, a change of −0.03. The latest reported quarter, Q2 2026 · Jun 30, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IGC Pharma source filings ↗